170 related articles for article (PubMed ID: 6245044)
1. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Cox JD; Byhardt RW; Komaki R; Greenberg M
Int J Radiat Oncol Biol Phys; 1980 Jan; 6(1):37-40. PubMed ID: 6245044
[No Abstract] [Full Text] [Related]
2. [Clinical study on radiotherapy in combination with misonidazole].
Ono K; Takahashi M; Dodo Y; Abe M
Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
[No Abstract] [Full Text] [Related]
3. The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02).
Fazekas JT; Goodman RL; McLean CJ
Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1703-8. PubMed ID: 7333912
[No Abstract] [Full Text] [Related]
4. [Radiotherapy of malignant tumors of the maxillofacial region].
Vorob'ev IuI
Vestn Rentgenol Radiol; 1985; (3):76-9. PubMed ID: 3929458
[No Abstract] [Full Text] [Related]
5. A report on misonidazole in randomized trial in locally advanced head and neck cancer.
Sealy R; Williams A; Cridland S; Stratford M; Minchinton A; Hallet C
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):339-42. PubMed ID: 7050035
[TBL] [Abstract][Full Text] [Related]
6. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
Sealy R; Cridland S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
[TBL] [Abstract][Full Text] [Related]
7. Combinations of radiation and misonidazole in a murine lung tumor model.
Siemann DW; Kochanski K
Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
[No Abstract] [Full Text] [Related]
8. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
Ono K; Sasai K; Shibamoto Y; Tsutsui K; Fushiki M; Nishidai T; Takahashi M; Abe M
Gan No Rinsho; 1987 Oct; 33(13):1673-8. PubMed ID: 2961900
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bladder carcinoma with irradiation combined with misonidazole.
Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated radiotherapy with or without misonidazole: results of a prospective randomized study in stage III-IV squamous cell carcinoma of the head and neck.
Panis X; Nguyen TD; Froissart D; Demange L
Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1845-9. PubMed ID: 6386760
[TBL] [Abstract][Full Text] [Related]
11. [Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Suyama S; Yabumoto E; Furunishi H; Kawanishi K; Yamazaki T; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(10):998-1003. PubMed ID: 7335473
[No Abstract] [Full Text] [Related]
12. Sensitizers and radiation dose fractionation: results and interpretations.
Hill RP
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1049-54. PubMed ID: 2943705
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
Van den Bogaert W; van der Schueren E; Horiot JC; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1649-55. PubMed ID: 7153077
[TBL] [Abstract][Full Text] [Related]
14. A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus.
Saunders MI; Anderson P; Dische S; Martin WM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):347-50. PubMed ID: 7050036
[No Abstract] [Full Text] [Related]
15. [Initial experience with the use of hypoxic hypoxia in clinical radiotherapy].
Sarkisian IuKh; Kir'ianov IIu; Karibov IuI
Med Radiol (Mosk); 1977 Dec; 22(12):10-3. PubMed ID: 600043
[No Abstract] [Full Text] [Related]
16. Radiotherapy in non-small cell lung cancer: present progress and future perspectives.
Van Houtte P; Salazar OM; Henry J
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):997-1006. PubMed ID: 6432542
[No Abstract] [Full Text] [Related]
17. Clinical dose-response curve of subclinical aggregates of epithelial cells.
Fletcher GH
J Radiol Electrol Med Nucl; 1972 Mar; 53(3):201-6. PubMed ID: 5051022
[No Abstract] [Full Text] [Related]
18. Changes in tumor oxygen tension during radiation therapy.
Badib AO; Webster JH
Acta Radiol Ther Phys Biol; 1969 Jun; 8(3):247-57. PubMed ID: 4980755
[No Abstract] [Full Text] [Related]
19. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
[No Abstract] [Full Text] [Related]
20. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
Curtis SB; Tenforde TS; Afzal SM
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
